Day: June 30, 2023

Government Institution Adopts SS Innovations International’s SSi Mantra Surgical Robotic System

Written by Customer Service on June 30, 2023. Posted in Public Companies.

FORT LAUDERDALE, FL, June 30, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announces the first successful surgical procedure at the National Institute of Tuberculosis and Respiratory Diseases (NITRD) in New Delhi, India using the SSi Mantra surgical robotic system. NITRD is the first Central Government Institution in India to purchase SS Innovations’ state-of-the-art SSi Mantra surgical robotic system, and the first Indian hospital with national status to conduct robotic surgery using the indigenous SSi Mantra surgical robotic system. NITRD Director, Dr. Ravindra Kumar Dewan, and consultant thoracic...

Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China

Written by Customer Service on June 30, 2023. Posted in Public Companies.

First-and-only approved FcRn antagonist for gMG patients by NMPA 68% of anti-AChR antibody positive gMG patients treated with VYVGART were responders (n=44/65) on the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale compared with 30% of patients treated with placebo (n=19/64) (p

Regency Centers Invites You to Join Its Second Quarter 2023 Earnings Conference Call

Written by Customer Service on June 30, 2023. Posted in Public Companies.

JACKSONVILLE, Fla., June 30, 2023 (GLOBE NEWSWIRE) — Regency Centers Corporation (The “Company”) (NASDAQ: REG) will announce its Second Quarter 2023 earnings results on Thursday, August 3, 2023, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Friday, August 4, 2023, at 11:00 a.m. ET.Second Quarter 2023 Earnings Conference CallDate: Friday, August 4, 2023Time: 11:00 a.m. ETDial#: 877-407-0789 or 201-689-8562Webcast: 2nd Quarter 2023 Webcast Link Replay Webcast Archive: Investor Relations page under Webcasts & Presentations About Regency Centers Corporation (NASDAQ: REG) Regency Centers is a...

C3is Inc. Announces Pricing of $5 Million Public Offering

Written by Customer Service on June 30, 2023. Posted in Public Companies.

ATHENS, Greece, June 30, 2023 (GLOBE NEWSWIRE) — C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing drybulk seaborne transportation services, announced today that it has entered into a securities purchase agreement with a single institutional investor to purchase 4,765,000 units at a price of $1.05 per unit containing a common share and a price of $1.04 per unit containing a pre-funded warrant in lieu of a common share. Each unit consists of one common share (or pre-funded warrant in lieu thereof) and one Class A warrant to purchase one common share, and will immediately separate upon issuance. The gross proceeds of the offering to the Company, before discounts and commissions and estimated offering expenses, are expected to be approximately $5.0 million. Each Class A warrant is immediately exercisable for...

Bannix Acquisition Corp. Announces Entering into a Business Combination Agreement with Evie Autonomous Group Ltd.

Written by Customer Service on June 30, 2023. Posted in Mergers And Acquisitions.

Developer of Ai Technologies and Autonomous Future Mobility Platforms for Industrial & Commercial Environments. “At Evie we move people and goods autonomously” WEST HOLLYWOOD, Calif., June 30, 2023 (GLOBE NEWSWIRE) — Bannix Acquisition Corp. (NASDAQ: BNIX), a publicly traded special purpose acquisition company, is thrilled to announce that it has entered into a definitive agreement to acquire Evie Autonomous Group Ltd, a private company based in England and Wales. This business combination agreement marks a significant milestone for both companies and represents a major leap forward in the autonomous technology sector. Evie Autonomous operates in the off highway industrial & commercial future autonomous mobility markets. It has a complete proven autonomous technologies stack using its Ai Radar vision sensor that can be...

Baudax Bio Acquires TeraImmune, Inc.

Written by Customer Service on June 30, 2023. Posted in Mergers And Acquisitions.

TeraImmune, an Advanced Treg Research Company, headed by Yong Chan Kim, Ph D, brings an approved Treg IND to the Strong Development team from Baudax Baudax Bio CEO Gerri Henwood to Serve as CEO of Combined Entity MALVERN, Pa., June 30, 2023 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (Nasdaq:BXRX) (“Baudax Bio” or the “Company”), a pharmaceutical company focused on innovative products for acute care and related settings, today announced the acquisition of TeraImmune, a privately held a biotechnology company focused on discovery and development of novel Treg-based cell therapies for autoimmune diseases. “This combination blends the world class scientific expertise of the TeraImmune team with the Baudax team’s proven ability to execute clinical development programs, which we believe is a win for the shareholders of both companies,” said...

Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum

Written by Customer Service on June 30, 2023. Posted in Public Companies.

IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that the company’s management team will participate at the SVB Securities Therapeutics Forum. SVB Securities Therapeutics ForumDate: Tuesday, July 11th – Wednesday, July 12th, 2023Location: The Lotte Palace, New York, N.Y. About Reneo PharmaceuticalsReneo is a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). Our lead product candidate, mavodelpar (REN001), is...

Resignation of Director

Written by Customer Service on June 30, 2023. Posted in Public Companies.

About Adyton For more information about Adyton, visit www.adytonresources.comPORT MORESBY, Papua New Guinea, June 30, 2023 (GLOBE NEWSWIRE) — Adyton Resources Corporation (TSX Venture: ADY) announces that Mr Anthony Williamson has resigned from the board of directors of the Company, and the board has accepted his resignation. The Board thanks Mr Williamson for his valuable contributions and wishes him every success in his future endeavours. ON BEHALF OF THE BOARD OF ADYTON RESOURCES CORPORATION Tim Crossley, Chief Executive Officer For further information please contact: Tim Crossley, Chief Executive Officer E‐mail: tcrossley@adtyonresources.comPhone: +61 7 3854 2389 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility...

Constellation Brands Reports First Quarter Fiscal 2024 Financial Results

Written by Customer Service on June 30, 2023. Posted in Earnings Releases And Operating Results.

VICTOR, N.Y., June 30, 2023 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its first quarter fiscal 2024 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Friday, June 30, 2023 at 10:30 a.m. EDT. Visit ir.cbrands.com to locate information for joining the conference call or a live, listen-only webcast of the conference call. ABOUT CONSTELLATION BRANDS Constellation Brands (NYSE: STZ) is a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Our mission is to build brands that people love because we believe elevating human connections is Worth...

9/2023・Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them

Written by Customer Service on June 30, 2023. Posted in Public Companies.

Company announcement no. 9 / 2023 Schindellegi, Switzerland – 30 June 2023 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them Pursuant to the Market Abuse Regulation Article 19, Trifork Holding AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by a person closely associated with a person discharging managerial responsibilities in Trifork.1. Details of the person discharging managerial responsibilities/person closely associateda) Name Trifork A/S2. Reason for the notificationa) Position/status The chair of Trifork A/S, Jesper Grankær Carøe, is a person discharging managerial responsibilities in Trifork, and Trifork A/S is therefore closely associated...

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30

Day: June 30, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice